Natco Pharma Ltd. — Investor Relations & Filings
Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Shareholders meeting | 2024-03-27 | English | |
| Trading Window | 2024-03-26 | English | |
| Loss of Share Certificates | 2024-03-12 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2024-03-02 | English | |
| Loss of Share Certificates | 2024-03-01 | English | |
| Change in Management | 2024-02-29 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 42628760 | Shareholders meeting | 2024-03-27 | English | ||
| 42641603 | Trading Window | 2024-03-26 | English | ||
| 42631392 | Loss of Share Certificates | 2024-03-12 | English | ||
| 42670541 | Analysts/Institutional Investor Meet/Con. Call Updates | 2024-03-02 | English | ||
| 42678570 | Loss of Share Certificates | 2024-03-01 | English | ||
| 42645614 | Change in Management | 2024-02-29 | English | ||
| 42661650 | Copy of Newspaper Publication | 2024-02-27 | English | ||
| 42677890 | Analysts/Institutional Investor Meet/Con. Call Updates | 2024-02-23 | English | ||
| 42655710 | Shareholders meeting | 2024-02-22 | English | ||
| 42659881 | Analysts/Institutional Investor Meet/Con. Call Updates | 2024-02-21 | English | ||
| 42656387 | Analysts/Institutional Investor Meet/Con. Call Updates | 2024-02-15 | English | ||
| 42661320 | Copy of Newspaper Publication | 2024-02-15 | English | ||
| 42663789 | Investor Presentation | 2024-02-15 | English | ||
| 42673809 | Updates | 2024-02-14 | English | ||
| 42682125 | Change in Director(s) | 2024-02-14 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Natco Pharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62741/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62741 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62741 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62741 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62741}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Natco Pharma Ltd. (id: 62741)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.